Equity · Healthcare
MDLN
NASDAQMedline (MDLN)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.
- Market cap
- 52.4B USD
- Revenue, year to Dec 2025
- 28.4B USD
- EPS, diluted, year to Dec 2025
- −0.01 USD
- 52-week range
- 33.21 USD – 50 USD
- Avg volume
- 2.4M
as of Jul 17, 2026
Have Medline (MDLN) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, Medline insiders reported 6 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 5 Jun 2026.
Form 4, 90 days to 10 Nov 2026, newest reported trade 8 Oct 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 08 Oct 2026 | GIC Private Ltd10% Owner | Sell | 7,816,987 | 274.8M USD |
| 06 Oct 2026 | GIC Private Ltd10% Owner | Sell | 9,272,000 | 325.0M USD |
| 05 Oct 2026 | GIC Private Ltd10% Owner | Sell | 1,688,690 | 60.4M USD |
| 02 Oct 2026 | GIC Private Ltd10% Owner | Sell | 9,717,940 | 336.2M USD |
| 14 Aug 2026 | GIC Private Ltd10% Owner | Sell | 100,000 | 3.6M USD |
| 13 Aug 2026 | GIC Private Ltd10% Owner | Sell | 1,500,000 | 53.7M USD |
| Sold | 6 open-market sales | 30,095,617 | $1,053.69M |
Which funds hold Medline (MDLN)?
10 of the 45 institutional funds we track reported a Medline position for the quarter ended 30 Jun 2026 — a combined 1.2B USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Lone Pine Capital | Added | 20,968,367 | 827.0M USD | +77.9% |
| Viking Global Investors | Trimmed | 4,841,080 | 190.9M USD | −57.7% |
| Soros Fund Management | Added | 1,638,244 | 64.6M USD | +27.3% |
| Millennium Management | Trimmed | 1,066,126 | 42.0M USD | −45.5% |
| Tudor Investment Corp | New position | 384,695 | 15.2M USD | |
| Two Sigma Investments | Trimmed | 194,567 | 7.7M USD | −82.9% |
| Citadel Advisors | Trimmed | 32,586 | 1.3M USD | −98.0% |
| Man Group | New position | 23,379 | 922K USD | |
| Bridgewater Associates | New position | 19,847 | 783K USD | |
| AQR Capital Management | New position | 10,726 | 423K USD |
What has been filed or recorded for Medline (MDLN)?
The filings we hold for Medline, newest first: 7 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 593 shares | 21K USD notional · <0.001% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 860 shares | 31K USD notional · <0.001% of shares out |
| 07 Oct 2026 | Fails to deliver | Shares failed to deliver | 1,829,628 shares | 65.0M USD notional · 0.217% of shares out |
| 02 Oct 2026 | Fails to deliver | Shares failed to deliver | 29,589 shares | 1.0M USD notional · 0.004% of shares out |
| 01 Oct 2026 | Fails to deliver | Shares failed to deliver | 69,500 shares | 2.4M USD notional · 0.008% of shares out |
| 30 Sep 2026 | Fails to deliver | Shares failed to deliver | 16,700 shares | 584K USD notional · 0.002% of shares out |
| 29 Sep 2026 | Fails to deliver | Shares failed to deliver | 2,826 shares | 99K USD notional · <0.001% of shares out |
| 26 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 0.22 USD | Revenue $7.86B |
| 26 Sep 2026 | Financials | Total assets | 40.2B USD | at period end |
| 26 Sep 2026 | Financials | Total equity | 11.8B USD | at period end |
| 27 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 0.07 USD | Revenue $7.69B |
| 28 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 0.16 USD | Revenue $7.35B |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −0.01 USD | Revenue $28.43B |
| 31 Dec 2025 | Financials | Revenue | 28.4B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 1.2B USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −0.01 USD | fiscal year |
| 27 Sep 2025 | Quarterly earnings | Q3 2026 reported | Revenue $7.12B | |
| 28 Jun 2025 | Quarterly earnings | Q2 2026 reported | Revenue $6.89B | |
| 29 Mar 2025 | Quarterly earnings | Q1 2026 reported | Revenue $6.64B | |
| 31 Dec 2024 | Annual report | FY 2025 reported | Revenue $25.51B |
What do people ask about Medline (MDLN)?
What is Medline’s market cap?52.4B
Medline is worth 52.4B USD by market value as of 17 Jul 2026, which is the share price times the shares on issue from its SEC filings.
What is Medline’s revenue?28.4B
Medline reported revenue of 28.4B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Medline insiders bought or sold shares recently?6 sales
In the 90 days to 10 Nov 2026, Medline insiders reported 6 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 5 Jun 2026. See Insiders
Which funds own Medline?10 of 45
10 of the 45 funds we track reported a Medline position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Lone Pine Capital, Viking Global Investors and Soros Fund Management. See Funds
When did Medline last report earnings?0.22
Medline last reported earnings on 26 Sep 2026 for Q3 2026, with EPS of 0.22 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 26 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings